Suppr超能文献

头颈部癌症的分子发病机制。

The molecular pathogenesis of head and neck cancer.

机构信息

Department of Otolaryngology, University of Pittsburgh School of Medicine and University of Pittsburgh Cancer Institute, Eye and Ear Institute Building, Pittsburgh, PA, USA.

出版信息

Cancer Biol Ther. 2010 Jan;9(1):1-7. doi: 10.4161/cbt.9.1.10905. Epub 2010 Jan 9.

Abstract

Head and neck cancer arises from a series of molecular alterations progressive from dysplasia to carcinoma in situ, and finally invasive carcinoma. Risk factors associated with head and neck cancer include tobacco, alcohol and viral infection. There are genetic alterations in pre-cancerous cells that contribute to transformation. The accumulation of these alterations facilitates tumor development. Additionally, the tumor microenvironment enables tumor progression. The cooperative effect of molecular alterations in the tumor cells and compensatory microenvironment changes enable tumors to invade and metastasize. This review focuses on the genes and molecules altered during the progression of head and neck cancer with an emphasis on the genetic, molecular and phenotypic changes during the pathogenesis of head and neck cancer. Therapeutic strategies that target key changes in the tumor cells and/or stromal cells in the tumor microenvironment are discussed.

摘要

头颈部癌症源于一系列分子改变,从发育异常进展为原位癌,最终发展为浸润性癌。与头颈部癌症相关的危险因素包括烟草、酒精和病毒感染。在癌前细胞中存在导致转化的遗传改变。这些改变的积累促进了肿瘤的发展。此外,肿瘤微环境促进肿瘤进展。肿瘤细胞中分子改变的协同作用和补偿性微环境变化使肿瘤能够侵袭和转移。本综述重点介绍了头颈部癌症进展过程中改变的基因和分子,强调了头颈部癌症发病机制过程中的遗传、分子和表型变化。讨论了针对肿瘤细胞和/或肿瘤微环境中基质细胞关键改变的治疗策略。

相似文献

1
The molecular pathogenesis of head and neck cancer.
Cancer Biol Ther. 2010 Jan;9(1):1-7. doi: 10.4161/cbt.9.1.10905. Epub 2010 Jan 9.
2
Clinical and molecular aspects of squamous cell carcinoma of the head and neck in the nonsmoker and nondrinker.
Curr Opin Oncol. 1997 May;9(3):257-61. doi: 10.1097/00001622-199709030-00007.
3
Distinct effects of alcohol consumption and smoking on genetic alterations in head and neck carcinoma.
PLoS One. 2013 Nov 20;8(11):e80828. doi: 10.1371/journal.pone.0080828. eCollection 2013.
4
Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing.
Ann Oncol. 2015 Jun;26(6):1216-1223. doi: 10.1093/annonc/mdv109. Epub 2015 Feb 23.
6
Molecular biology of squamous cell carcinoma of the head and neck.
J Clin Pathol. 2006 May;59(5):445-53. doi: 10.1136/jcp.2003.007641.
9
Human papillomavirus and p53 mutations in head and neck squamous cell carcinoma among Japanese population.
Cancer Sci. 2014 Apr;105(4):409-17. doi: 10.1111/cas.12369. Epub 2014 Mar 30.

引用本文的文献

1
Immunotherapy in Head and Neck Cancer.
Cancer Treat Res. 2025;129:119-156. doi: 10.1007/978-3-031-97242-3_7.
2
Advances and challenges in CAR-T cell therapy for head and neck squamous cell carcinoma.
Biomark Res. 2025 May 1;13(1):69. doi: 10.1186/s40364-025-00783-1.
3
Targeted radionuclide therapy for head and neck squamous cell carcinoma: a review.
Front Oncol. 2024 Aug 22;14:1445191. doi: 10.3389/fonc.2024.1445191. eCollection 2024.
4
Macrophages in head and neck squamous cell carcinoma: A bibliometric analysis.
Medicine (Baltimore). 2023 Dec 15;102(50):e36649. doi: 10.1097/MD.0000000000036649.
7
Biomarker Discovery in Rare Malignancies: Development of a miRNA Signature for RDEB-cSCC.
Cancers (Basel). 2023 Jun 22;15(13):3286. doi: 10.3390/cancers15133286.
8
Potential Alternative Therapeutic Modalities for Management Head and Neck Squamous Cell Carcinoma: A Review.
Cancer Control. 2023 Jan-Dec;30:10732748231185003. doi: 10.1177/10732748231185003.
9
The role of YAP in the control of the metastatic potential of oral cancer.
Oncol Res. 2022 Nov 10;29(6):377-391. doi: 10.32604/or.2022.026085. eCollection 2021.

本文引用的文献

2
Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications.
Clin Cancer Res. 2009 Nov 15;15(22):6758-62. doi: 10.1158/1078-0432.CCR-09-0784. Epub 2009 Oct 27.
4
Humanized anti-interleukin-6 receptor antibody suppresses tumor angiogenesis and in vivo growth of human oral squamous cell carcinoma.
Clin Cancer Res. 2009 Sep 1;15(17):5426-34. doi: 10.1158/1078-0432.CCR-09-0287. Epub 2009 Aug 25.
5
Phase II study of sunitinib malate in head and neck squamous cell carcinoma.
Invest New Drugs. 2010 Oct;28(5):677-83. doi: 10.1007/s10637-009-9296-7. Epub 2009 Aug 4.
6
Targeting PI3K signalling in cancer: opportunities, challenges and limitations.
Nat Rev Cancer. 2009 Aug;9(8):550-62. doi: 10.1038/nrc2664.
7
Overexpression of platelet-derived growth factor-BB increases tumor pericyte content via stromal-derived factor-1alpha/CXCR4 axis.
Cancer Res. 2009 Aug 1;69(15):6057-64. doi: 10.1158/0008-5472.CAN-08-2007. Epub 2009 Jul 7.
8
Current and potential inflammation targeted therapies in head and neck cancer.
Curr Opin Pharmacol. 2009 Aug;9(4):389-95. doi: 10.1016/j.coph.2009.06.005. Epub 2009 Jun 29.
9
HGF and c-Met participate in paracrine tumorigenic pathways in head and neck squamous cell cancer.
Clin Cancer Res. 2009 Jun 1;15(11):3740-50. doi: 10.1158/1078-0432.CCR-08-3252. Epub 2009 May 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验